Christopher Mutz, HEAD OF RARE DISEASE at ANI PHARMACEUTICALS INC (ANIP), sold 9,037 shares at $74.22 ($670K) on 2026-03-06, disclosed to the SEC on 2026-03-10.
Seasonal sale ($670k) by HEAD OF RARE DISEASE — this insider has traded ANIP in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.22 | 2,121 | $157K | 23.5% |
| 2 | $74.04 | 3,314 | $245K | 36.6% |
| 3 | $74.18 | 3,602 | $267K | 39.9% |
| Total | $74.14 avg | 9,037 | $670K | 100% |
| Filing → |
| ANIP | SELL | 2026-02-23 | $415K | — | Filing → |
| ANIP | SELL | 2026-02-17 | $538K | — | Filing → |
| ANIP | SELL | 2025-05-15 | $242K | — | Filing → |